-
KOSPI 2577.27 -2.21 -0.09%
-
KOSDAQ 722.52 -7.07 -0.97%
-
KOSPI200 341.49 +0.02 +0.01%
-
USD/KRW 1396 -2.00 0.14%
BAL0891
Search results
-
SillaJen Inc. said on Monday it has enrolled the first patient in a US phase 1 trial of an anti-cancer drug BAL0891 licensed from Swiss drugmaker Ba...
Feb 27, 2023 (Gmt+09:00)
